Blog

Genotyping vs Sequencing: Understanding the Key Differences

Genotyping vs Sequencing: Understanding the Key Differences

When it comes to understanding genetic variation, researchers often face a key choice – genotyping vs sequencing. Both are powerful genomic tools, but they reveal different levels of information. Genotyping by sequencing (GBS) and PCR-based genotyping each have unique strengths, costs, and applications. In this guide, we’ll break down what genotyping and sequencing are, highlight their key differences, and help you decide which method best fits your research goals.

What Is Genotyping?

Genotyping is the process of identifying specific genetic variations, most commonly single nucleotide polymorphisms (SNPs) or Indels, at known loci in the genome. The goal is not to sequence the entire genome but to detect the presence or absence of particular variants.

PCR genotyping, especially using allele-specific PCR techniques like PACE® (PCR Allele Competitive Extension), is a targeted approach ideal for screening large populations for known variants. This method is widely used for:

  • Marker-assisted selection (MAS)
  • Trait validation in plant and animal breeding
  • Genomic selection (GS)
  • Genetic purity in seed production
  • Research and Monitoring of disease risk, transmission and outcomes

With its high throughput, speed, and cost-effectiveness, PCR genotyping is a go-to method for focused, repeatable studies in agricultural genomics and life sciences.

What Is Sequencing?

Sequencing is the process of determining the exact order of nucleotides—adenine (A), thymine (T), cytosine (C), and guanine (G) in a DNA molecule. Unlike genotyping, which looks for known genetic variants, sequencing reveals the complete genetic information of an organism or sample. This provides a high-resolution view of genetic variation, enabling researchers to identify new mutations, study gene functions, and understand complex traits or diseases.

Modern sequencing technologies, such as next-generation sequencing (NGS), allow for rapid, large-scale DNA analysis at decreasing costs. As a result, sequencing has become an essential tool in biomedical research, diagnostics, and personalized medicine, helping scientists move from targeted detection to a comprehensive genomic perspective.

What Is Genotyping by Sequencing (GBS)?

Genotyping by sequencing (GBS) refers to sequencing-based methods for identifying genetic variation. This includes techniques like Next-Generation Sequencing (NGS) and whole-genome resequencing, which generate massive amounts of data to detect both known and novel variants across the genome.

GBS is especially useful for:

  • SNP discovery
  • De novo genome assembly
  • High-density genetic mapping
  • Population genomics
  • Research involving non-model organisms

Although more comprehensive, sequencing requires greater computational resources, higher costs, and longer turnaround times. It is often used in early-stage research or when genome-wide insights are needed.

Genotyping vs Sequencing

While genotyping and sequencing are both essential tools in modern genomics, they differ in scope, detail, and application. Understanding these differences helps researchers select the most efficient and cost-effective method for their study.

FeaturePCR GenotypingGenotyping by Sequencing
PurposeScreen known SNPs/IndelsDiscover and profile genome-wide variants
CostLow (especially per data point)High (especially for high-depth coverage)
SpeedFast (simple analysis pipeline)Slower (complex bioinformatics)
Data VolumeTargeted, focused outputHigh volume, requiring storage/analysis
ThroughputHigh (thousands of samples/day)Moderate (fewer samples, more depth)
Best UseMAS, validation, routine screeningDiscovery, mapping, diversity studies

Advantages of PCR Genotyping

  1. Efficiency PCR-based systems like PACE allow for extremely fast processing of large sample sets. With platforms like the 3CR GeneArrayer, researchers can process thousands of reactions per day.
  2. Cost-Effectiveness When working with a known set of markers (e.g. 1–100 SNPs), PCR genotyping dramatically lowers per-sample and per-marker costs compared to sequencing.
  3. Simplicity PCR genotyping does not require extensive data analysis. A simple fluorescence readout indicates genotype, making the process ideal for labs without dedicated bioinformatics support.
  4. Flexibility Custom primers can be developed from SNP-containing sequences without needing a full reference genome. PACE chemistry works well even in non-model species.
  5. High Sensitivity and Specificity Allele-specific PCR is well-suited to validate marker-trait associations with minimal false positives, which is critical in breeding programs.

Advantages of Genotyping by Sequencing

  1. Genome-Wide Discovery
    GBS methods allow detection of novel variants, including rare SNPs, structural variants, and insertions/deletions.
  2. High Marker Density
    Sequencing provides access to thousands or millions of markers, ideal for fine mapping or detailed population structure analysis.
  3. Broad Applications
    Sequencing is useful for evolutionary studies, de novo genome assembly, and any situation where prior marker knowledge is lacking.
  4. Future-Proofing
    Once sequencing data is generated, it can be reused or reanalyzed in the future for different research questions.

When to Choose Genotyping Over Sequencing

Genotyping is the preferred approach when speed, cost-efficiency, and targeted variant detection are key. PCR-based genotyping delivers reliable results without the depth or expense of full sequencing. It is ideal when:

  • The variants are already known, and the goal is to confirm their presence or absence.
  • Cost per data point is important, and large-scale screening must remain affordable.
  • High-throughput testing is required, such as analyzing many samples in a short time.
  • Real-time decision-making is critical, for example in breeding programs or diagnostics.
  • Sample input is limited or low quality, including crude materials like leaf punches or animal hair.

Case Study: Peanut Breeding at NC State University

At North Carolina State University’s Peanut Breeding & Genetics Program, researchers used PCR genotyping with PACE to streamline cultivar development. By targeting SNPs linked to key traits, they reduced genotyping time and cost, accelerating trait selection and variety release. Read more about their development pipeline here.

When to Choose Sequencing Over Genotyping

Use genotyping-by-sequencing when:

  • You’re working with non-model species with unknown markers
  • You need to build genetic maps or conduct association studies
  • You need to detect a broad spectrum of genomic variation
  • You’re conducting basic or exploratory research

Integration of Both Approaches

Often, the best approach is complementary use:

  • Use GBS to discover markers and identify candidate SNPs
  • Then use PCR genotyping (e.g. PACE) to validate and screen those markers in large populations

This pipeline supports robust, cost-effective breeding strategies where sequencing sets the stage and PCR delivers the practical results.

Scalable PCR Genotyping for Every Lab

3CR Bioscience’s PACE® technology offers unmatched flexibility for researchers needing fast, accurate, and scalable SNP genotyping:

  • Compatible with crude DNA and RNA inputs
  • Multiplexing up to 4 targets per reaction
  • Supports real-time or endpoint detection
  • Interoperable with KASP™ and Amplifluor systems

PACE 2.0 provides enhanced signal clarity and tight clustering, even from challenging DNA sources, PACE Multiplex allows multiple assays per reaction, while PACE OneStep RT-PCR enables direct RNA-to-genotype workflows.

Automating Genotyping with 3CR’s GeneArrayer Platform

To further improve throughput and reproducibility, 3CR offers a full suite of automation tools:

  • GeneExtract: Fast, high-yield DNA extraction
  • GeneArrayer: Automated PCR plate setup for high throughput
  • GeneCycler: Optimised thermal cycling
  • GeneScanner: High-resolution fluorescence detection

These tools work together to reduce hands-on time, standardise results, and cut costs for genotyping at scale.

Final Thoughts

Choosing between genotyping and sequencing depends on your goals, sample size, and budget. For focused, high-throughput screening of known variants, PCR genotyping remains the most efficient choice. For discovery-driven or genome-wide research, sequencing is unmatched in depth and detail.

At 3CR Bioscience, we help researchers build cost-effective, fit-for-purpose genotyping strategies with robust assay design, validated chemistry, and streamlined instrumentation.

Need help deciding between PCR genotyping and sequencing for your project? Contact us at support@3crbio.com — we’re here to help you choose the right tool for the job.


Case Study: Peanut Breeding at NC State University

At North Carolina State University’s Peanut Breeding & Genetics Program, researchers used PCR genotyping with PACE to streamline cultivar development. By targeting SNPs linked to key traits, they reduced genotyping time and cost, accelerating trait selection and variety release. Read more about their development pipeline in our case study.

MORE POSTS

PCR Steps in PACE High-Throughput Genotyping: From Sample Preparation to Fluorescence Detection
A practical walkthrough of PCR steps in PACE® genotyping, from sample prep to fluorescence readout.
Advancing Hemp Breeding with PACE® Genotyping: Insights from the Smart Lab at Cornell University
Learn how PACE® genotyping enables faster, more accurate hemp breeding.
Validating Complex Traits in Polyploid Crops: PACE® Genotyping in Rose GWAS Research
Learn how PACE® genotyping bridges the gap between GWAS discovery and marker-assisted selection in genetically complex, polyploid rose breeding.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR. 

Sign up now to receive insights, updates 
and industry case studies. 

This field is for validation purposes and should be left unchanged.
Name(Required)

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.